Janux Therapeutics Overview
Janux Therapeutics Target Price
Analysts' average 12-month price target for Janux Therapeutics is $29.
Get informed when a big investor buys or sells
+ FollowShare Price
$16.67
Average Target Price
$29.00
74% upside
74% upside7 analysts in the last 4 months
High: $55 | Low: $14
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-07 | Stifel Nicolaus | $35 | 110% upside |  |
| 2026-08-07 | Guggenheim | $55 | 229.9% upside | |
| 2026-06-25 | Truist Financial | $26 | 56% upside | |
| 2026-05-11 | Evercore ISI | $22 | 32% upside | |
| 2026-05-08 | Wedbush | $36 | 116% upside | |
| 2026-04-20 | BarclaysEtzer Darout | $14 |  16% downside | |
| 2026-04-15 | UBS | $15 | 10% downside | |
| 2026-01-16 | Piper SandlerKelsey Goodwin | $30 | 80% upside | |
| 2025-12-17 | Barclays | $29 | 74% upside | |
| 2025-12-02 | UBSDavid Dai | $57 | 241.9% upside | |
| 2025-12-02 | Stifel NicolausStephen Willey | $38 | 128% upside | |
| 2025-12-02 | H.C. Wainwright | $45 | 169.9% upside | |
| 2025-09-16 | Barclays | $47 | 181.9% upside | |
| 2025-09-10 | Stifel Nicolaus | $45 | 169.9% upside | |
| 2025-09-03 | GuggenheimBrad Canino | $72 | 331.9% upside | |
| 2025-07-11 | Raymond JamesSean McCutcheon | $65 | 289.9% upside | |
| 2025-02-28 | Scotiabank | $41 | 146% upside | |
| 2025-02-28 | Wedbush | $76 | 355.9% upside | |
| 2024-12-03 | BTIGJustin Zelin | $100 | 499.9% upside | |
| 2024-10-24 | UBSDavid Dai | $69 | 313.9% upside | |
| 2024-09-05 | Stifel NicolausBradley Canino | $70 | 319.9% upside | |
| 2024-08-09 | ScotiabankGeorge Farmer | $42 | 151.9% upside | |
| 2024-05-30 | ScotiabankGeorge Farmer | $47 | 181.9% upside | |
| 2024-05-13 | H.C. WainwrightSwayampakula Ramakanth | $63 | 277.9% upside | |
| 2024-03-20 | BTIGKaveri Pohlman | $62 | 271.9% upside | |